Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BSX - BOSTON SCIENTIFIC CORP


104.39
0.110   0.105%

Share volume: 5,173,825
Last Updated: Mon 24 Feb 2025 10:00:00 PM CET
Surgical and Medical Instrument Manufacturing : -0.21%

PREVIOUS CLOSE
CHG
CHG%

$104.28
-0.10
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
53%
Profitability 44%
Dept financing 47%
Liquidity 18%
Performance 72%
Company vs Stock growth
vs
Performance
5 Days
-0.92%
1 Month
2.07%
3 Months
16.96%
6 Months
31.36%
1 Year
56.58%
2 Year
122.96%
Key data
Stock price
$104.39
P/E Ratio 
71.04
DAY RANGE
$103.87 - $104.95
EPS 
$1.23
52 WEEK RANGE
$65.52 - $107.17
52 WEEK CHANGE
$57.14
MARKET CAP 
131.642 B
YIELD 
N/A
SHARES OUTSTANDING 
1.473 B
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.63
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,495,264
AVERAGE 30 VOLUME 
$6,212,836
Company detail
CEO: Michael F. Mahoney
Region: US
Website: bostonscientific.com
Employees: 45,000
IPO year: 1992
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions.

Recent news